The reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: The EORTC QLQ-BM22

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 14, Issue 1, 2014, Pages 147-156

  Yekaninejad, Mir S ^a   Ahmadzadeh, Ahmad ^b   Mosavi, Seyed H ^c   Saffari, Mohsen ^d   Pakpour, Amir H ^e   Tolooei, Fatemeh ^a   Chow, Edward ^f   Bottomley, Andrew ^g  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^g EORTC DATA CENTER   (Belgium)

Author keywords

Bone metastases; European Organisation for Research and Treatment of Cancer (EORTC) QLQ BM22; Factor structure; Health related quality of life; Multigroup confirmatory factor analysis

Indexed keywords

MORPHINE;

ADULT; ARTICLE; BONE METASTASIS; BONE PAIN; CANCER PAIN; CANCER PROGNOSIS; CLINICAL ASSESSMENT TOOL; COLORECTAL CARCINOMA; CONTROLLED STUDY; CRONBACH ALPHA COEFFICIENT; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE C30; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE WITH BONE METASTASES 22; FACTORIAL ANALYSIS; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; INTERMETHOD COMPARISON; INTERNAL CONSISTENCY; IRAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE MYELOMA; OVARY CANCER; PAIN ASSESSMENT; PANCREAS CANCER; PATIENT ATTITUDE; PERFORMANCE MEASUREMENT SYSTEM; PROSTATE CANCER; PSYCHOMETRY; QUALITY OF LIFE INDEX; RATING SCALE; SOCIAL PSYCHOLOGY; STATISTICAL ANALYSIS; YOUNG ADULT;

ADULT; BONE NEOPLASMS; FACTOR ANALYSIS, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRAN; MALE; MIDDLE AGED; PILOT PROJECTS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 84893129414     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/14737167.2014.864559     Document Type: Article

References (42)

1. Kurosaka S, Satoh T, Chow E et al. EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy. Ann. Nucl. Med. 26(6), 485-491 (2012
2. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin. Cancer Res. 12(20 Pt 2), 6243s-6249s (2006
3. Mundy GR. Metastasis to bone: Causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2(8), 584-593 (2002
4. Chow E, Nguyen J, Zhang L et al. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer 118(5), 1457-1465 (2012
5. Jensen AO, Jacobsen JB, Norgaard M, Yong M, Fryzek JP, Sorensen HT. Incidence of bone metastases and skeletal-related events in breast cancer patients: A population-based cohort study in Denmark. BMC Cancer 11, 29 (2011
6. Wardley A, Davidson N, Barrett-Lee P et al. Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: A randomised, crossover study of community vs hospital bisphosphonate administration. Br. J. Cancer 92(10), 1869-1876 (2005
7. Chow E, Hird A, Velikova G et al. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: The EORTC QLQ-BM22. Eur. J. Cancer 45(7), 1146-1152 (2009
8. Tubiana-Hulin M. Incidence, prevalence and distribution of bone metastases. Bone (12 Suppl. 1), S9-S10 (1991
9. Tharmalingam S, Chow E, Harris K, Hird A, Sinclair E. Quality of life measurement in bone metastases: A literature review. J. Pain Res. 1, 49-58 (2008
10. Soni MK, Cella D. Quality of life and symptom measures in oncology: An overview. Am. J. Manag. Care 8(18 Suppl.) S560-S573 (2002
11. Santoro M, Cicero G, Condemi G et al. Pain Management and quality life in bone metastasis from breast cancer: Role of radiotherapy. Cancer Treat. Rev. 36, S104-S104 (2010
12. Costa L, Major PP. Effect of bisphosphonates on pain and quality of life in patients with bone metastases. Nature Clinical Practice Oncology, 6(3), 163-174 (2009
13. Harris K, Chow E, Zhang L et al. Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases. Eur. J. Cancer 45(14), 2510-2518 (2009
14. Rustoen T, Moum T, Padilla G, Paul S, Miaskowski C. Predictors of quality of life in oncology outpatients with pain from bone metastasis. J. Pain Symptom Manage. 30(3), 234-242 (2005
15. Popovic M, Nguyen J, Chen E, Di Giovanni J, Zeng L, Chow E. Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases. Expert Rev. Pharmacoecon. Outcomes Res. 12(2), 213-219 (2012
16. Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQC30: A quality-of-life instrument for use in international clinical trials in oncology. J. Natl Cancer Inst. 85(5), 365-376 (1993
17. Montazeri A, Harirchi I, Vahdani M et al. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Translation and validation study of the Iranian version. Support Care Cancer 7(6), 400-406 (1999
18. Fayers PM, Aaronson NK, Bjordal K et al. The EORTC QLQ-C30 scoring manual (3rd Edition). European Organisation for Research and Treatment of Cancer, Brussels, Belgium (2001
19. Chow E, Wu JS, Hoskin P, Coia LR, Bentzen SM, Blitzer PH. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother. Oncol. 64(3), 275-280 (2002
20. Cull A, Sprangers MAG, Aaronson NK Internal report of the EORTC Study Group on Quality of Life: European Organization for Research and Treatment of Cancer quality of life study group translation procedure (1994
21. Khoshnevisan A, Yekaninejad MS, Ardakani SK, Pakpour AH, Mardani A, Aaronson NK. Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran. Health Qual. Life Outcomes, 10, 54
22. Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Qual. Life Res. 2(6), 441-449 (1993
23. Nunnally JC, Bernstein IR. Psychometric Theory (3rd Edition). McGraw-Hil, NY, USA (1994
24. Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychol. Rep. 19, 3-11 (1966
25. Bagozzi RP, Yi Y, Phillips LW. Assessing construct validity in organizational research. Adm. Sci. Q. 36, 421-458. (1991
26. Fayers PM, Machin D. Quality of Life: Assessment, Analysis and Interpretation John Wiley & Sons, Chichester, UK (2000
27. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. Royal Statistical Society: Series B 57, 289-300 (1995
28. Cohen J. A power primer. Psychol. Bull 112, 155-159 (1992
29. Browne MW, Cudeck R. Alternative ways of assessing model fit. Sociological Methods Res. 21, 230-258 (1992
30. Jöreskog KG, Sörbom D. LISREL 8.80 for Windows [Computer Software]. Scientific Software International Inc., Lincolnwood, IL, USA (2006
31. Mahjoubi B, Mirzaei R, Azizi R, Jafarinia M, Zahedi-Shoolami L. A cross-sectional survey of quality of life in colostomates: A report from Iran. Health Qual. Life Outcomes 10, 136 (2012
32. Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S. Using reference data on quality of life-the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). Eur. J. Cancer 34, 1381-1389 (1998
33. French B, Finch W. Confirmatory factor analytic procedures for the determination of measurement invariance. Struct. Equation Model. 13, 378-402 (2006
34. Cheung GW, Rensvold RB. Evaluating goodness-of-fit indexes for testing measurement invariance. Struct. Equation Model. 9, 233-255 (2002
35. Horn JL, McArdle JJ. A practical and theoretical guide to measurement invariance in aging research. Exp. Aging Res. 18, 117-144 (1992
36. Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med. Care 28(7), 632-642 (1990
37. Chow E, Nguyen J, Zhang LY et al. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer 118(5), 1457-1465 (2012
38. Pud D. Gender differences in predicting quality of life in cancer patients with pain. Eur. J. Oncol. Nurs. 15(5), 486-491 (2011
39. Miaskowski C. Gender differences in pain, fatigue, and depression in patients with cancer. J. Natl Cancer Inst. Monogr. (32), 139-143 (2004
40. Fouladbakhsh JM, Stommel M. Gender, symptom experience, and use of complementary and alternative medicine practices among cancer survivors in the U.S. cancer population. Oncol. Nurs. Forum, 37(1), E7-E15 (2010
41. Harris K, Chow E, Zhang L et al. Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases. Eur. J. Cancer 45, 2510-2518 (2009
42. Bernhard J, Ganz PA. Psychosocial issues in lung cancer patients (Part 1). Chest 99(1), 216-223 (1991